🚁 Exciting update from LinaThera! We've completed a comprehensive drone survey, capturing topographical data to advance our project. A special thanks to Ulf Klose for his professional execution of the drone flight. Check out our photos for a glimpse from above! 📸✨ #LinaThera #Innovation #radionuclides #RLT
LinaThera
Arzneimittelherstellung
Forchheim, Bavaria 194 Follower:innen
Sustainable Production of Medical Radioisotopes
Info
LinaThera is developing a facility for the production of medical radionuclides for cancer therapy: Sustainable, without the use of nuclear reactors, and involving regional clinics. Radionligand therapy is rapidly gaining popularity worldwide as a targeted, gentle form of cancer treatment. The supply of medical radioisotopes is a well-known bottleneck in the provision and treatment of cancer patients. Unlike conventional sources, LinaThera does not rely on nuclear reactors but produces medical radioisotopes in a sustainable facility that makes a significant contribution to supply and is also scalable.
- Website
-
https://linathera.com
Externer Link zu LinaThera
- Branche
- Arzneimittelherstellung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Forchheim, Bavaria
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2022
Orte
-
Primär
Äußere Nürnberger Straße 62
Forchheim, Bavaria 91301, DE
Beschäftigte von LinaThera
Updates
-
LinaThera hat dies direkt geteilt
Together with LinaThera and Dr Christoph Thiel, our CEO Dr Leila Jaafar recently visited the Medical Valley EMN e. V. in Forchheim for an inspiring event on innovative companies in the region. We had the honor of meeting Hallerndorf's mayor Gerhard Bauer, the Bavarian Minister of Economic Affairs Hubert Aiwanger and the Minister of State for the Environment and Consumer Protection Thorsten Glauber. We are grateful for the opportunity to contribute to the fight against cancer and for the support of our collaborative project with LinaThera. Catch the full TV report here: https://lnkd.in/dGVNAfE8 Zusammen mit LinaThera und Dr. Christoph Thiel hat unsere Geschäftsführerin Dr. Leila Jaafar erneut das Medical Valley EMN e. V. in Forchheim zu einer innovativen Veranstaltung besucht. Dabei waren unter anderem Hallerndorfs Bürgermeister Gerhard Bauer, der bayrische Wirtschaftsminister Hubert Aiwanger und der Staatsminister für Umwelt und Verbraucherschutz Thorsten Glauber. Wir bedanken uns recht herzlich für die Möglichkeit, unseren Beitrag zur Krebsbekämpfung leisten zu können, und für die Unterstützung des gemeinsamen Projekts mit LinaThera. Zum TV Oberfranken Bericht: https://lnkd.in/dGVNAfE8
Der bayerische Wirtschaftsminister Hubert Aiwanger und Umweltminister Thorsten Glauber besuchten kürzlich das Medical Valley Center in 📍Forchheim, um sich ein Bild von den aktuellen 📈Entwicklungen in der Region zu machen. Bereits im Februar diesen Jahres waren die Minister vor Ort, um sich über das Ökosystem Medical Valley zu 💡informieren. 👉 Lesen Sie alle Themen und Entwicklungen, die im Rahmen des Besuchs behandelt wurden, im Beitrag auf unserer Website nach: https://lnkd.in/dWJ94H8R Hubert Aiwanger | Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie | Bayerisches Staatsministerium für Umwelt und Verbraucherschutz | Christoph Thiel | Leila Jaafar | Martin Haensel | NUCLIDIUM AG | LinaThera | Anlagenbau Neundörfer GmbH | IBL- Löttechnik GmbH | Siemens Energy | Wirtschaftsförderung Forchheim #MedicalValley #MedicalValleyCenterForchheim #Forchheim
-
LinaThera hat dies direkt geteilt
Herzlichen Dank 💝 für die tollen Beiträge und Berichtserstattung!! Pro Concept Unternehmensberatung hat eine Beitragsserie in Ihrem Newsletter gestartet, wo sie über die Radioligandentherapie und deren Beitrag zur Krebsbekämpfung berichten. Mit Feature zu LinaThera und NUCLIDIUM AG - super Sache Fischer Heinz Peter und Daniel Kanin 🙏 🙏 🙏 Lesen Sie hier: https://lnkd.in/ekc7rw5Y TV Oberfranken berichtete zur Medical Valley EMN e. V. Veranstaltung in Forchheim mit Minister Hubert Aiwanger und Thorsten Glauber. Auch dabei: Leila Jaafar von NUCLIDIUM AG und Christoph Thiel von LinaThera Sehen Sie hier (vielen Dank 🙏 Barbara von Bohnstein): https://lnkd.in/dGVNAfE8
-
Herzlichen Dank 💝 für die tollen Beiträge und Berichtserstattung!! Pro Concept Unternehmensberatung hat eine Beitragsserie in Ihrem Newsletter gestartet, wo sie über die Radioligandentherapie und deren Beitrag zur Krebsbekämpfung berichten. Mit Feature zu LinaThera und NUCLIDIUM AG - super Sache Fischer Heinz Peter und Daniel Kanin 🙏 🙏 🙏 Lesen Sie hier: https://lnkd.in/ekc7rw5Y TV Oberfranken berichtete zur Medical Valley EMN e. V. Veranstaltung in Forchheim mit Minister Hubert Aiwanger und Thorsten Glauber. Auch dabei: Leila Jaafar von NUCLIDIUM AG und Christoph Thiel von LinaThera Sehen Sie hier (vielen Dank 🙏 Barbara von Bohnstein): https://lnkd.in/dGVNAfE8
-
Site Secured: LinaThera acquired a 12,000 sqm site for radionuclide production! 🔏 🤝 🚧 The contract was signed by Hallerndorf Mayor Gerhard Bauer and our CEO Christoph Thiel. Planning and licensing are next. We thank Bavarian state ministers Hubert Aiwanger (Economic Affairs) and Thorsten Glauber (Environment), the district of Forchheim and Medical Valley EMN e. V. / Forchheim CEP, Viktor Naumann for their support. https://lnkd.in/dusYMufr #CancerCare #Radionuclides #Radiopharmaceuticals 📸 Stephan Grossmann / Fraenkischer Tag
-
LinaThera hat dies direkt geteilt
An exciting afternoon with state ministers at the Medical Valley Center in Forchheim: Ministers Hubert Aiwanger and Thorsten Glauber were informed about the innovative strength of the region. Anlagenbau Neundörfer GmbH and LinaThera both founded resp. owned by #FAUalums, gave thrilling insights. Special thanks to Martin Haensel, CEO of Neundoerfer Anlagenbau, for the invitation. FAU Erlangen-Nürnberg
-
LinaThera hat dies direkt geteilt
NUCLIDIUM is partnering with Guerbet! As a long-standing expert in the field of diagnostic imaging, Guerbet has a wealth of knowledge and an extensive network in diagnostic imaging, manufacturing, and clinical trials. We will draw on these valuable resources to reach our goal of accelerating the development of our pipeline towards clinical proof-of-concept and ensuring reliable supply chains for copper-based radiopharmaceuticals. Looking forward to our collaboration and to gaining strategic insights from Francois Nicolas and his team at Guerbet! #CancerCare #CancerDiagnostics #MedicalImaging #PrecisionOncology #Radiopharmaceuticals #Radiotheranostics #Theranostics
-
🎉 Exciting News at LinaThera! 🎉 We’re thrilled to announce that we are winners of the second round (again after the first round) of the Northern Bavaria 2024 Business Plan Competition! 🏆 This recognition highlights our innovative strides in cancer diagnostics and therapy technology. Stay tuned for more updates! 🔬✨ thanks for great support Medical Valley EMN e. V. NUCLIDIUM AG BayStartUP and 📸 Bert Willer, 🎬 Tobias Bladowski #startup #Innovation #radionuclides #RLT
-
LinaThera hat dies direkt geteilt
⚡ Exciting developments at Nuclidium as we prepare for LSX - partnering for Life Science eXecutives! ⚡ Investments by industry giants like Lilly and BMS highlight the potential and competitive nature of the radiopharmaceutical sector. Here’s why you should meet with Leila Jaafar and Andreas Schuh on the 29th and 30th of April in London: ✅ Innovative Theranostics: Our Cu-61 and Cu-67 pairs offer precise diagnosis and targeted treatment, improving efficacy and minimizing side effects for major cancers such as breast, prostate, lung, and pancreatic. ✅ Advanced Diagnostics: Cu-61’s longer half-life and superior properties simplify manufacturing and extend usability, enhancing diagnostic applications. ✅ Effective Therapeutics: Cu-67 aligns perfectly with our targeting molecules, allowing for higher tumor dosage with reduced toxicity and shorter hospital stays. ✅ Sustainable Production: In collaboration with LinaThera, our proprietary, scalable production facilities are independent of nuclear reactors, beginning in Germany with plans for global expansion. With commitments secured and a strategic investor on board, we're gearing to close Series A2 in Q3. Join us at LSX - partnering for Life Science eXecutives to discover how our cutting-edge solutions are poised to revolutionize cancer treatment. #LSX #Radiopharmaceuticals #InvestInInnovation #LinaThera #Nuclidium
-
LinaThera hat dies direkt geteilt
Check out GE HealthCare’s video series on radiopharmaceuticals ahead of #SNMMI2024, featuring our CEO, Leila Jaafar. Leila explains the versatile potential of radioisotopes in oncology and beyond, as well as the impact of radiometals on the future of nuclear medicine: https://lnkd.in/d87cZ_fc #CancerCare #PrecisionOncology #Radiopharmaceuticals #Radiotheranostics #Theranostics
Dr. Leila Jaafar-Thiel: Radiometals impact on future of nuclear medicine
https://www.youtube.com/